| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaginosis, Bacterial | 14 | 2016 | 127 | 1.690 |
Why?
|
| Vagina | 26 | 2011 | 825 | 1.670 |
Why?
|
| Bacteroides fragilis | 42 | 2000 | 212 | 1.400 |
Why?
|
| Bacteria | 23 | 2016 | 2102 | 1.280 |
Why?
|
| Microbiological Techniques | 3 | 2016 | 102 | 1.110 |
Why?
|
| Superantigens | 4 | 2010 | 129 | 1.060 |
Why?
|
| Enterotoxins | 8 | 2013 | 368 | 1.010 |
Why?
|
| Staphylococcus aureus | 15 | 2019 | 1449 | 0.990 |
Why?
|
| Bacteroides Infections | 26 | 2000 | 82 | 0.970 |
Why?
|
| Staphylococcal Infections | 15 | 2019 | 1398 | 0.970 |
Why?
|
| Bacterial Toxins | 14 | 2013 | 933 | 0.940 |
Why?
|
| Obstetric Labor, Premature | 7 | 2010 | 279 | 0.910 |
Why?
|
| Abdominal Abscess | 10 | 2003 | 154 | 0.880 |
Why?
|
| Menstruation | 7 | 2010 | 299 | 0.840 |
Why?
|
| Pregnancy Complications, Infectious | 13 | 2015 | 2026 | 0.730 |
Why?
|
| Feces | 15 | 2019 | 1394 | 0.730 |
Why?
|
| Wound Infection | 8 | 2019 | 240 | 0.690 |
Why?
|
| Placenta | 10 | 2019 | 1694 | 0.680 |
Why?
|
| Communicable Diseases | 3 | 2016 | 878 | 0.650 |
Why?
|
| Bacteriological Techniques | 8 | 2010 | 276 | 0.620 |
Why?
|
| Microbiology | 1 | 2018 | 72 | 0.620 |
Why?
|
| Carbapenems | 4 | 2022 | 117 | 0.610 |
Why?
|
| Gastroesophageal Reflux | 2 | 2015 | 782 | 0.600 |
Why?
|
| Polysaccharides, Bacterial | 25 | 2000 | 578 | 0.580 |
Why?
|
| Clostridium | 14 | 2021 | 98 | 0.570 |
Why?
|
| Carrier State | 3 | 2010 | 518 | 0.560 |
Why?
|
| Anti-Bacterial Agents | 29 | 2022 | 7153 | 0.560 |
Why?
|
| Antibodies, Bacterial | 12 | 2010 | 1469 | 0.550 |
Why?
|
| Microbial Interactions | 2 | 2013 | 76 | 0.530 |
Why?
|
| Saliva | 1 | 2019 | 805 | 0.520 |
Why?
|
| Bacteria, Anaerobic | 8 | 2019 | 68 | 0.510 |
Why?
|
| DNA, Bacterial | 7 | 2016 | 1465 | 0.500 |
Why?
|
| Diagnostic Tests, Routine | 4 | 2016 | 783 | 0.490 |
Why?
|
| Antacids | 1 | 2014 | 99 | 0.490 |
Why?
|
| Oropharynx | 1 | 2015 | 127 | 0.480 |
Why?
|
| Stomach | 2 | 2015 | 697 | 0.460 |
Why?
|
| Abscess | 26 | 2000 | 607 | 0.450 |
Why?
|
| Stomach Diseases | 1 | 2014 | 134 | 0.450 |
Why?
|
| Trichomonas vaginalis | 1 | 2013 | 76 | 0.440 |
Why?
|
| Gardnerella vaginalis | 2 | 2006 | 13 | 0.430 |
Why?
|
| Bacterial Infections | 9 | 2014 | 1389 | 0.430 |
Why?
|
| Lactobacillus | 9 | 2019 | 189 | 0.420 |
Why?
|
| Immunity, Innate | 4 | 2013 | 2956 | 0.400 |
Why?
|
| Urea | 2 | 2004 | 449 | 0.390 |
Why?
|
| Clindamycin | 17 | 2004 | 139 | 0.390 |
Why?
|
| Enterocolitis, Pseudomembranous | 12 | 2004 | 264 | 0.380 |
Why?
|
| Shock, Septic | 4 | 2005 | 773 | 0.370 |
Why?
|
| Colony Count, Microbial | 10 | 2013 | 331 | 0.370 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2013 | 687 | 0.370 |
Why?
|
| Nasal Cavity | 2 | 2010 | 312 | 0.360 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 521 | 0.360 |
Why?
|
| Chorioamnionitis | 4 | 2012 | 155 | 0.350 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2010 | 140 | 0.350 |
Why?
|
| Enterobacteriaceae Infections | 3 | 2017 | 186 | 0.350 |
Why?
|
| Bacteroides | 18 | 1990 | 161 | 0.330 |
Why?
|
| Clostridium Infections | 10 | 2021 | 548 | 0.330 |
Why?
|
| Symbiosis | 3 | 2021 | 283 | 0.320 |
Why?
|
| Infant, Premature | 7 | 2014 | 2041 | 0.320 |
Why?
|
| Naphthyridines | 2 | 1999 | 118 | 0.320 |
Why?
|
| Probiotics | 3 | 2007 | 351 | 0.320 |
Why?
|
| Ureaplasma urealyticum | 1 | 2008 | 38 | 0.320 |
Why?
|
| Enterobacteriaceae | 7 | 2017 | 169 | 0.320 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 4 | 2008 | 143 | 0.320 |
Why?
|
| RNA, Ribosomal, 16S | 6 | 2019 | 947 | 0.310 |
Why?
|
| Prevotella | 2 | 1998 | 79 | 0.310 |
Why?
|
| Intestines | 13 | 2014 | 1923 | 0.310 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2018 | 232 | 0.310 |
Why?
|
| Mycoplasma | 1 | 2008 | 139 | 0.310 |
Why?
|
| Epithelial Cells | 3 | 2013 | 3678 | 0.300 |
Why?
|
| Bacteremia | 7 | 2013 | 962 | 0.300 |
Why?
|
| Enterobacter cloacae | 2 | 2019 | 20 | 0.300 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2010 | 602 | 0.290 |
Why?
|
| Streptococcus agalactiae | 3 | 2005 | 375 | 0.290 |
Why?
|
| Interleukin-1 | 6 | 2006 | 1262 | 0.290 |
Why?
|
| beta-Lactamases | 3 | 2019 | 303 | 0.290 |
Why?
|
| Colitis, Ulcerative | 15 | 2010 | 1901 | 0.290 |
Why?
|
| Pregnancy Trimester, Second | 7 | 2010 | 732 | 0.290 |
Why?
|
| Fluoroquinolones | 2 | 1999 | 308 | 0.290 |
Why?
|
| Escherichia coli Infections | 5 | 2008 | 532 | 0.290 |
Why?
|
| beta-Lactam Resistance | 2 | 2017 | 79 | 0.270 |
Why?
|
| Pseudomonas Infections | 3 | 2019 | 608 | 0.270 |
Why?
|
| Culture Techniques | 1 | 2006 | 554 | 0.260 |
Why?
|
| Menstrual Hygiene Products | 4 | 1989 | 18 | 0.260 |
Why?
|
| Cecum | 9 | 2021 | 237 | 0.260 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2008 | 406 | 0.250 |
Why?
|
| Disease Models, Animal | 37 | 2016 | 18006 | 0.250 |
Why?
|
| History, 20th Century | 4 | 2018 | 2739 | 0.250 |
Why?
|
| Gels | 2 | 2003 | 427 | 0.250 |
Why?
|
| Pregnancy | 33 | 2019 | 29087 | 0.250 |
Why?
|
| Metronidazole | 4 | 1999 | 217 | 0.240 |
Why?
|
| Lung Diseases | 1 | 2014 | 1884 | 0.240 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2022 | 145 | 0.240 |
Why?
|
| Gentamicins | 10 | 2019 | 253 | 0.240 |
Why?
|
| Cytokines | 10 | 2011 | 7317 | 0.230 |
Why?
|
| Bacterial Adhesion | 2 | 2004 | 316 | 0.230 |
Why?
|
| Escherichia coli | 18 | 2019 | 4214 | 0.230 |
Why?
|
| Culture Media | 7 | 2010 | 902 | 0.230 |
Why?
|
| Minocycline | 3 | 2019 | 163 | 0.200 |
Why?
|
| Burns | 4 | 2019 | 1809 | 0.200 |
Why?
|
| Microbial Sensitivity Tests | 11 | 2019 | 1871 | 0.200 |
Why?
|
| Female | 81 | 2019 | 379592 | 0.200 |
Why?
|
| Klebsiella pneumoniae | 2 | 2015 | 246 | 0.200 |
Why?
|
| Bacterial Capsules | 4 | 1999 | 251 | 0.190 |
Why?
|
| Rats, Wistar | 10 | 2003 | 1902 | 0.190 |
Why?
|
| Cervix Uteri | 2 | 2004 | 591 | 0.190 |
Why?
|
| Immunization | 8 | 1995 | 1255 | 0.190 |
Why?
|
| Lung | 3 | 2015 | 9826 | 0.190 |
Why?
|
| History, 21st Century | 2 | 2018 | 1533 | 0.190 |
Why?
|
| Colitis | 6 | 2014 | 1149 | 0.180 |
Why?
|
| Blood | 6 | 2011 | 598 | 0.180 |
Why?
|
| Humans | 130 | 2022 | 742088 | 0.180 |
Why?
|
| Publishing | 4 | 2016 | 833 | 0.180 |
Why?
|
| Carrageenan | 10 | 1988 | 66 | 0.180 |
Why?
|
| Rats | 40 | 2003 | 24265 | 0.180 |
Why?
|
| Germ-Free Life | 8 | 2021 | 188 | 0.170 |
Why?
|
| Lipopolysaccharides | 6 | 2004 | 2211 | 0.170 |
Why?
|
| Peptostreptococcus | 2 | 1998 | 27 | 0.170 |
Why?
|
| Acinetobacter Infections | 1 | 2019 | 69 | 0.170 |
Why?
|
| Tissue Adhesions | 2 | 1999 | 235 | 0.170 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2019 | 134 | 0.170 |
Why?
|
| HLA-B27 Antigen | 1 | 1998 | 76 | 0.170 |
Why?
|
| Amino Acids | 4 | 2021 | 1727 | 0.170 |
Why?
|
| Sepsis | 6 | 2012 | 2589 | 0.170 |
Why?
|
| Filtration | 1 | 2019 | 234 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 7 | 2014 | 2552 | 0.160 |
Why?
|
| Animals | 98 | 2021 | 168561 | 0.160 |
Why?
|
| Acetobacter | 1 | 2018 | 6 | 0.160 |
Why?
|
| Peritoneal Diseases | 4 | 1990 | 75 | 0.160 |
Why?
|
| Fetal Growth Retardation | 3 | 2012 | 570 | 0.160 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 1999 | 122 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2005 | 638 | 0.160 |
Why?
|
| Vancomycin | 7 | 2019 | 500 | 0.160 |
Why?
|
| Anti-Infective Agents | 2 | 2011 | 971 | 0.160 |
Why?
|
| Membranes, Artificial | 1 | 1999 | 378 | 0.160 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 1000 | 0.160 |
Why?
|
| Models, Biological | 6 | 2011 | 9581 | 0.150 |
Why?
|
| Ileitis | 3 | 1994 | 44 | 0.150 |
Why?
|
| Genes, Bacterial | 3 | 2015 | 1078 | 0.150 |
Why?
|
| Methicillin Resistance | 2 | 2008 | 198 | 0.150 |
Why?
|
| Antitoxins | 4 | 2010 | 82 | 0.150 |
Why?
|
| R Factors | 1 | 2017 | 44 | 0.150 |
Why?
|
| T-Lymphocytes | 13 | 2012 | 10163 | 0.150 |
Why?
|
| Infant, Extremely Low Birth Weight | 3 | 2012 | 89 | 0.150 |
Why?
|
| Nonlinear Dynamics | 1 | 1999 | 502 | 0.140 |
Why?
|
| Gestational Age | 7 | 2015 | 3490 | 0.140 |
Why?
|
| Guinea Pigs | 12 | 2004 | 1386 | 0.140 |
Why?
|
| Virulence | 10 | 2021 | 1328 | 0.140 |
Why?
|
| Proctocolectomy, Restorative | 3 | 1994 | 189 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2010 | 4414 | 0.140 |
Why?
|
| Carbon Dioxide | 1 | 2000 | 1141 | 0.140 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2018 | 740 | 0.140 |
Why?
|
| Microcephaly | 2 | 2010 | 430 | 0.140 |
Why?
|
| Ammonia | 1 | 1997 | 239 | 0.140 |
Why?
|
| Clotrimazole | 1 | 1995 | 77 | 0.140 |
Why?
|
| Automation, Laboratory | 1 | 2016 | 101 | 0.130 |
Why?
|
| Ecosystem | 3 | 2012 | 471 | 0.130 |
Why?
|
| Female Urogenital Diseases | 1 | 2015 | 52 | 0.130 |
Why?
|
| Developmental Disabilities | 2 | 2015 | 1452 | 0.130 |
Why?
|
| Metagenome | 3 | 2014 | 417 | 0.130 |
Why?
|
| Anal Canal | 2 | 2010 | 376 | 0.130 |
Why?
|
| Intestinal Mucosa | 9 | 2014 | 3038 | 0.130 |
Why?
|
| Premature Birth | 5 | 2011 | 1713 | 0.130 |
Why?
|
| Pneumonia, Bacterial | 1 | 2018 | 316 | 0.130 |
Why?
|
| Pregnancy Outcome | 4 | 2011 | 2795 | 0.120 |
Why?
|
| Lyme Disease | 2 | 1991 | 618 | 0.120 |
Why?
|
| Borrelia burgdorferi Group | 2 | 1991 | 97 | 0.120 |
Why?
|
| Streptococcal Infections | 4 | 2005 | 637 | 0.120 |
Why?
|
| Intelligence | 1 | 2019 | 920 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 1997 | 1799 | 0.120 |
Why?
|
| Citrobacter rodentium | 1 | 2014 | 65 | 0.120 |
Why?
|
| Phagocytes | 1 | 1996 | 297 | 0.120 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2015 | 766 | 0.120 |
Why?
|
| Cellulose | 2 | 2011 | 123 | 0.120 |
Why?
|
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2013 | 23 | 0.120 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2005 | 261 | 0.120 |
Why?
|
| Male | 72 | 2019 | 349538 | 0.120 |
Why?
|
| Esophageal pH Monitoring | 1 | 2015 | 190 | 0.120 |
Why?
|
| Biguanides | 1 | 2013 | 23 | 0.120 |
Why?
|
| Cytotoxins | 6 | 1997 | 153 | 0.120 |
Why?
|
| Interleukin-10 | 4 | 2004 | 1200 | 0.110 |
Why?
|
| CpG Islands | 1 | 2017 | 1170 | 0.110 |
Why?
|
| Peritonitis | 5 | 1995 | 365 | 0.110 |
Why?
|
| Enterococcus | 2 | 2008 | 158 | 0.110 |
Why?
|
| DNA Transposable Elements | 1 | 2017 | 748 | 0.110 |
Why?
|
| Candidiasis | 1 | 1995 | 365 | 0.110 |
Why?
|
| Wound Healing | 4 | 2019 | 2781 | 0.110 |
Why?
|
| Bacillaceae Infections | 1 | 2012 | 8 | 0.110 |
Why?
|
| Security Measures | 2 | 2003 | 77 | 0.110 |
Why?
|
| Genetic Variation | 3 | 2017 | 6540 | 0.110 |
Why?
|
| Acetates | 4 | 1992 | 312 | 0.110 |
Why?
|
| Inflammation | 5 | 2017 | 10578 | 0.110 |
Why?
|
| Bacteria, Aerobic | 3 | 2008 | 25 | 0.110 |
Why?
|
| Bacillus cereus | 1 | 2012 | 35 | 0.110 |
Why?
|
| Placenta Diseases | 3 | 2012 | 195 | 0.110 |
Why?
|
| Swine | 8 | 2019 | 5934 | 0.110 |
Why?
|
| Povidone-Iodine | 1 | 1992 | 59 | 0.110 |
Why?
|
| Bioterrorism | 2 | 2003 | 143 | 0.100 |
Why?
|
| Glucans | 1 | 1992 | 72 | 0.100 |
Why?
|
| Infant, Newborn | 15 | 2014 | 25575 | 0.100 |
Why?
|
| Quality Control | 1 | 2015 | 841 | 0.100 |
Why?
|
| Adult | 31 | 2019 | 213712 | 0.100 |
Why?
|
| Cricetinae | 11 | 2004 | 2471 | 0.100 |
Why?
|
| Carboxymethylcellulose Sodium | 2 | 2003 | 39 | 0.100 |
Why?
|
| Dog Diseases | 2 | 1990 | 136 | 0.100 |
Why?
|
| Horse Diseases | 2 | 1989 | 57 | 0.100 |
Why?
|
| Mesocricetus | 7 | 2004 | 251 | 0.100 |
Why?
|
| Immunity | 1 | 2017 | 1011 | 0.100 |
Why?
|
| Oxygen | 3 | 2000 | 4169 | 0.100 |
Why?
|
| Dogs | 3 | 1991 | 3910 | 0.100 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2012 | 347 | 0.100 |
Why?
|
| Deoxycholic Acid | 1 | 2011 | 52 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2010 | 561 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2019 | 1032 | 0.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 4 | 2007 | 404 | 0.100 |
Why?
|
| Puerperal Infection | 1 | 2011 | 46 | 0.100 |
Why?
|
| Actinomycetales | 1 | 2011 | 31 | 0.100 |
Why?
|
| beta-Glucans | 1 | 1992 | 123 | 0.100 |
Why?
|
| Actinomycetales Infections | 1 | 2011 | 30 | 0.100 |
Why?
|
| Diabetes Complications | 2 | 2009 | 1359 | 0.100 |
Why?
|
| Editorial Policies | 1 | 2016 | 451 | 0.100 |
Why?
|
| Biocompatible Materials | 1 | 1999 | 1731 | 0.100 |
Why?
|
| Proteus mirabilis | 1 | 2010 | 25 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 1995 | 729 | 0.100 |
Why?
|
| Pleurisy | 1 | 2011 | 53 | 0.100 |
Why?
|
| Electric Impedance | 1 | 2015 | 727 | 0.100 |
Why?
|
| Francisella tularensis | 1 | 2011 | 56 | 0.090 |
Why?
|
| Salmonella enterica | 1 | 2010 | 75 | 0.090 |
Why?
|
| Executive Function | 1 | 2019 | 1362 | 0.090 |
Why?
|
| Carbohydrates | 2 | 1992 | 391 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 6171 | 0.090 |
Why?
|
| Immunity, Cellular | 6 | 1990 | 1606 | 0.090 |
Why?
|
| Antigens, CD1d | 2 | 2009 | 220 | 0.090 |
Why?
|
| Ceftizoxime | 1 | 1990 | 4 | 0.090 |
Why?
|
| Urine | 1 | 2012 | 370 | 0.090 |
Why?
|
| Albumins | 1 | 2013 | 568 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2010 | 14720 | 0.090 |
Why?
|
| Bifidobacterium | 1 | 2010 | 100 | 0.090 |
Why?
|
| Adolescent | 10 | 2019 | 85649 | 0.090 |
Why?
|
| Antigens, Bacterial | 13 | 2004 | 1170 | 0.090 |
Why?
|
| Pseudomonas aeruginosa | 4 | 2019 | 1210 | 0.090 |
Why?
|
| Gram-Negative Anaerobic Bacteria | 3 | 1979 | 16 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 944 | 0.090 |
Why?
|
| Administration, Topical | 3 | 2016 | 688 | 0.090 |
Why?
|
| Borrelia Infections | 1 | 1989 | 17 | 0.090 |
Why?
|
| Infant, Premature, Diseases | 2 | 2014 | 706 | 0.090 |
Why?
|
| Peritoneal Cavity | 1 | 1989 | 148 | 0.090 |
Why?
|
| Child Behavior Disorders | 1 | 2014 | 807 | 0.090 |
Why?
|
| Bronchoscopy | 1 | 2015 | 860 | 0.090 |
Why?
|
| Lung Transplantation | 1 | 2018 | 1155 | 0.090 |
Why?
|
| Immunologic Tests | 1 | 1990 | 103 | 0.080 |
Why?
|
| beta-Defensins | 1 | 2009 | 57 | 0.080 |
Why?
|
| Immunity, Mucosal | 1 | 2012 | 491 | 0.080 |
Why?
|
| Abdomen | 10 | 1994 | 1107 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 1998 | 1538 | 0.080 |
Why?
|
| Laryngoscopy | 1 | 2015 | 706 | 0.080 |
Why?
|
| Chemokines | 1 | 2013 | 954 | 0.080 |
Why?
|
| Anesthesia, Epidural | 1 | 2011 | 227 | 0.080 |
Why?
|
| Housekeeping, Hospital | 1 | 2008 | 17 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 3 | 1997 | 1676 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2015 | 859 | 0.080 |
Why?
|
| Prenatal Diagnosis | 2 | 2014 | 1232 | 0.080 |
Why?
|
| Polymorphism, Genetic | 3 | 2010 | 4328 | 0.080 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2009 | 75 | 0.080 |
Why?
|
| Infant | 9 | 2015 | 35070 | 0.080 |
Why?
|
| Patients' Rooms | 1 | 2008 | 63 | 0.080 |
Why?
|
| Hyaluronic Acid | 2 | 2003 | 489 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 3862 | 0.080 |
Why?
|
| Respiratory Sounds | 1 | 2012 | 693 | 0.080 |
Why?
|
| Head | 2 | 2010 | 878 | 0.080 |
Why?
|
| Child, Preschool | 8 | 2015 | 40955 | 0.080 |
Why?
|
| Interleukin-8 | 2 | 2004 | 689 | 0.080 |
Why?
|
| Cells, Cultured | 7 | 2013 | 19223 | 0.080 |
Why?
|
| Vancomycin Resistance | 1 | 2008 | 128 | 0.080 |
Why?
|
| Mice | 28 | 2021 | 81045 | 0.080 |
Why?
|
| Milk | 1 | 2010 | 449 | 0.080 |
Why?
|
| Enterobacter | 3 | 2014 | 46 | 0.080 |
Why?
|
| Time Factors | 9 | 2012 | 40054 | 0.080 |
Why?
|
| Plasmids | 4 | 2022 | 2305 | 0.070 |
Why?
|
| Disease Outbreaks | 1 | 2017 | 1768 | 0.070 |
Why?
|
| Sialoglycoproteins | 2 | 2006 | 318 | 0.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 689 | 0.070 |
Why?
|
| Macrophages | 4 | 2011 | 5655 | 0.070 |
Why?
|
| Prospective Studies | 9 | 2022 | 53187 | 0.070 |
Why?
|
| Child | 8 | 2019 | 77478 | 0.070 |
Why?
|
| Carbohydrate Sequence | 6 | 2000 | 414 | 0.070 |
Why?
|
| Ascitic Fluid | 4 | 2008 | 192 | 0.070 |
Why?
|
| Fermentation | 2 | 2021 | 143 | 0.070 |
Why?
|
| Bacterial Proteins | 4 | 2017 | 3843 | 0.070 |
Why?
|
| Nose | 1 | 2010 | 509 | 0.070 |
Why?
|
| Retinopathy of Prematurity | 1 | 2011 | 421 | 0.070 |
Why?
|
| Immunization, Passive | 7 | 1994 | 625 | 0.070 |
Why?
|
| Erythromycin | 2 | 2004 | 120 | 0.070 |
Why?
|
| Sampling Studies | 1 | 2008 | 623 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2019 | 8297 | 0.070 |
Why?
|
| Tetracycline | 2 | 1978 | 214 | 0.070 |
Why?
|
| Nitric Oxide | 2 | 2006 | 2128 | 0.070 |
Why?
|
| Pregnancy Complications | 2 | 2012 | 2861 | 0.070 |
Why?
|
| Periodicals as Topic | 2 | 2016 | 1431 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 1998 | 2410 | 0.070 |
Why?
|
| Interleukins | 1 | 2010 | 791 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 2 | 2014 | 1477 | 0.070 |
Why?
|
| Infant Food | 2 | 1983 | 141 | 0.060 |
Why?
|
| Serotyping | 2 | 2004 | 338 | 0.060 |
Why?
|
| Cerebral Palsy | 1 | 2010 | 459 | 0.060 |
Why?
|
| Anaerobiosis | 8 | 2010 | 140 | 0.060 |
Why?
|
| Species Specificity | 7 | 2012 | 2479 | 0.060 |
Why?
|
| Vaginal Smears | 2 | 2006 | 511 | 0.060 |
Why?
|
| Exudates and Transudates | 2 | 2003 | 171 | 0.060 |
Why?
|
| Water | 1 | 2011 | 1388 | 0.060 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 170 | 0.060 |
Why?
|
| Restriction Mapping | 1 | 2004 | 878 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2763 | 0.060 |
Why?
|
| Probability | 3 | 2005 | 2502 | 0.060 |
Why?
|
| Education, Medical | 1 | 2016 | 1717 | 0.060 |
Why?
|
| Phagocytosis | 1 | 1989 | 1538 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2019 | 21719 | 0.060 |
Why?
|
| Boston | 6 | 2019 | 9305 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2017 | 4282 | 0.060 |
Why?
|
| Butyrates | 3 | 2021 | 163 | 0.060 |
Why?
|
| Cohort Studies | 10 | 2012 | 40450 | 0.060 |
Why?
|
| Rats, Inbred Strains | 3 | 1992 | 2191 | 0.060 |
Why?
|
| Computers | 2 | 1999 | 611 | 0.060 |
Why?
|
| Fever | 1 | 2011 | 1612 | 0.060 |
Why?
|
| Prevalence | 3 | 2010 | 15194 | 0.060 |
Why?
|
| Logistic Models | 6 | 2014 | 13403 | 0.060 |
Why?
|
| Salicylates | 1 | 1983 | 126 | 0.060 |
Why?
|
| Risk Factors | 12 | 2014 | 72145 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 822 | 0.060 |
Why?
|
| Middle Aged | 13 | 2019 | 213127 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 3 | 2006 | 1167 | 0.060 |
Why?
|
| Molecular Sequence Data | 8 | 2015 | 18112 | 0.050 |
Why?
|
| Lymphocyte Activation | 3 | 2012 | 5519 | 0.050 |
Why?
|
| Cesarean Section | 2 | 2008 | 1363 | 0.050 |
Why?
|
| Cell Line | 3 | 2011 | 15994 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 4 | 1998 | 860 | 0.050 |
Why?
|
| Young Adult | 4 | 2019 | 56350 | 0.050 |
Why?
|
| Colestipol | 2 | 1978 | 10 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 2016 | 1420 | 0.050 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 39004 | 0.050 |
Why?
|
| Clostridium perfringens | 2 | 1979 | 27 | 0.050 |
Why?
|
| RNA | 1 | 2012 | 2747 | 0.050 |
Why?
|
| Streptococcus pyogenes | 1 | 2004 | 289 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 972 | 0.050 |
Why?
|
| Cell Degranulation | 3 | 2009 | 287 | 0.050 |
Why?
|
| Information Services | 1 | 2003 | 244 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 1 | 2002 | 251 | 0.050 |
Why?
|
| Bacterial Outer Membrane Proteins | 3 | 2004 | 404 | 0.050 |
Why?
|
| Polyamines | 2 | 1978 | 120 | 0.050 |
Why?
|
| Genome, Bacterial | 2 | 2017 | 754 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 12 | 2012 | 21821 | 0.050 |
Why?
|
| Phylogeny | 3 | 2014 | 2797 | 0.050 |
Why?
|
| Science | 1 | 2003 | 241 | 0.050 |
Why?
|
| Terrorism | 1 | 2003 | 211 | 0.050 |
Why?
|
| Automation | 2 | 2012 | 584 | 0.040 |
Why?
|
| Access to Information | 1 | 2003 | 320 | 0.040 |
Why?
|
| Antigens, CD1 | 1 | 2002 | 437 | 0.040 |
Why?
|
| Sudden Infant Death | 1 | 1982 | 291 | 0.040 |
Why?
|
| Unnecessary Procedures | 2 | 2003 | 431 | 0.040 |
Why?
|
| Age Distribution | 1 | 2005 | 2900 | 0.040 |
Why?
|
| Child Language | 1 | 2019 | 64 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2013 | 3679 | 0.040 |
Why?
|
| Keratinocytes | 2 | 2016 | 797 | 0.040 |
Why?
|
| Antibiosis | 1 | 1999 | 46 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3649 | 0.040 |
Why?
|
| Multilocus Sequence Typing | 1 | 2019 | 99 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 15494 | 0.040 |
Why?
|
| Fusobacterium | 7 | 1979 | 54 | 0.040 |
Why?
|
| Conjugation, Genetic | 1 | 2019 | 126 | 0.040 |
Why?
|
| Rodent Diseases | 1 | 1978 | 57 | 0.040 |
Why?
|
| Acinetobacter baumannii | 1 | 2019 | 107 | 0.040 |
Why?
|
| Bacillus | 2 | 1994 | 77 | 0.040 |
Why?
|
| Staphylococcus | 4 | 1994 | 155 | 0.040 |
Why?
|
| Leukocyte Count | 4 | 1992 | 1583 | 0.040 |
Why?
|
| Therapeutic Irrigation | 2 | 2006 | 300 | 0.040 |
Why?
|
| Alginates | 1 | 2019 | 250 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2021 | 1119 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2885 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 2004 | 2867 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 3381 | 0.040 |
Why?
|
| Peritoneum | 2 | 1982 | 226 | 0.040 |
Why?
|
| Biological Availability | 1 | 1998 | 396 | 0.040 |
Why?
|
| Spleen | 2 | 2003 | 2359 | 0.040 |
Why?
|
| Systems Biology | 1 | 2021 | 469 | 0.040 |
Why?
|
| Arginine | 1 | 2021 | 944 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2010 | 2024 | 0.040 |
Why?
|
| Streptococcus | 5 | 1994 | 197 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2012 | 4231 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2019 | 9846 | 0.040 |
Why?
|
| Microscopy, Electron | 6 | 1993 | 2645 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2012 | 4030 | 0.040 |
Why?
|
| Urinary Tract Infections | 1 | 2003 | 786 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2007 | 3199 | 0.040 |
Why?
|
| Research | 2 | 2003 | 1999 | 0.040 |
Why?
|
| Anticholesteremic Agents | 1 | 2005 | 979 | 0.040 |
Why?
|
| Corynebacterium | 4 | 1994 | 47 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 1998 | 533 | 0.040 |
Why?
|
| Hospital Information Systems | 1 | 2000 | 395 | 0.040 |
Why?
|
| Enterococcus faecium | 1 | 1998 | 102 | 0.040 |
Why?
|
| Transformation, Bacterial | 1 | 2017 | 78 | 0.040 |
Why?
|
| Data Display | 1 | 1997 | 182 | 0.040 |
Why?
|
| Risk Assessment | 6 | 2012 | 23320 | 0.040 |
Why?
|
| Horses | 2 | 1989 | 304 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 1978 | 388 | 0.040 |
Why?
|
| Methylene Blue | 1 | 1997 | 155 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3769 | 0.040 |
Why?
|
| Intestine, Small | 2 | 2009 | 1243 | 0.040 |
Why?
|
| Cross Reactions | 2 | 1995 | 841 | 0.040 |
Why?
|
| Fungi | 2 | 2012 | 327 | 0.040 |
Why?
|
| Phenylurea Compounds | 1 | 1999 | 526 | 0.030 |
Why?
|
| Women's Health | 1 | 2006 | 2034 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 10943 | 0.030 |
Why?
|
| Protein Deficiency | 1 | 1996 | 61 | 0.030 |
Why?
|
| Multivariate Analysis | 3 | 2012 | 12242 | 0.030 |
Why?
|
| Polymers | 1 | 1983 | 1618 | 0.030 |
Why?
|
| Aerobiosis | 3 | 2010 | 106 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1999 | 6452 | 0.030 |
Why?
|
| Colon | 3 | 2010 | 1773 | 0.030 |
Why?
|
| Random Allocation | 2 | 2016 | 2425 | 0.030 |
Why?
|
| Postpartum Hemorrhage | 1 | 2019 | 258 | 0.030 |
Why?
|
| Cecal Diseases | 3 | 1981 | 51 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1997 | 362 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1999 | 730 | 0.030 |
Why?
|
| Invertebrate Hormones | 1 | 1995 | 26 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 4801 | 0.030 |
Why?
|
| Prevotella melaninogenica | 3 | 1979 | 13 | 0.030 |
Why?
|
| Proteus vulgaris | 1 | 2014 | 7 | 0.030 |
Why?
|
| Biological Assay | 1 | 1997 | 652 | 0.030 |
Why?
|
| Mast Cells | 2 | 1992 | 1544 | 0.030 |
Why?
|
| Hydrogels | 1 | 2019 | 723 | 0.030 |
Why?
|
| Breast Feeding | 3 | 2012 | 1339 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2006 | 297 | 0.030 |
Why?
|
| Intestinal Diseases | 1 | 1979 | 531 | 0.030 |
Why?
|
| Specimen Handling | 2 | 1997 | 692 | 0.030 |
Why?
|
| Cross Infection | 2 | 2017 | 1413 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2014 | 153 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 24913 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 2 | 2008 | 424 | 0.030 |
Why?
|
| Molecular Structure | 2 | 1995 | 1907 | 0.030 |
Why?
|
| Lactic Acid | 1 | 1999 | 1132 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 1998 | 1546 | 0.030 |
Why?
|
| Debridement | 1 | 2016 | 492 | 0.030 |
Why?
|
| Clone Cells | 1 | 2017 | 1692 | 0.030 |
Why?
|
| Doxycycline | 1 | 1975 | 326 | 0.030 |
Why?
|
| False Positive Reactions | 2 | 2000 | 981 | 0.030 |
Why?
|
| RNA Probes | 1 | 1992 | 113 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1707 | 0.030 |
Why?
|
| Acetic Acid | 1 | 1992 | 55 | 0.030 |
Why?
|
| Postnatal Care | 1 | 2014 | 235 | 0.030 |
Why?
|
| Administration, Intravaginal | 1 | 1992 | 147 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 1999 | 1887 | 0.030 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1992 | 94 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 2257 | 0.030 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2012 | 106 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 1992 | 354 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2013 | 57683 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 527 | 0.030 |
Why?
|
| Listeriosis | 1 | 2012 | 149 | 0.030 |
Why?
|
| DNA Probes | 1 | 1992 | 560 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 17400 | 0.020 |
Why?
|
| Ileum | 1 | 1994 | 565 | 0.020 |
Why?
|
| Leukocytes | 1 | 2019 | 2039 | 0.020 |
Why?
|
| Exocytosis | 1 | 1993 | 353 | 0.020 |
Why?
|
| Toll-Like Receptors | 2 | 2004 | 592 | 0.020 |
Why?
|
| Filgrastim | 1 | 2010 | 132 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 4 | 2009 | 6382 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 1996 | 963 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2007 | 5180 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1992 | 548 | 0.020 |
Why?
|
| Herpesvirus 2, Human | 1 | 2012 | 185 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2012 | 250 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2012 | 380 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 1994 | 551 | 0.020 |
Why?
|
| Term Birth | 1 | 2011 | 135 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1998 | 8300 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1993 | 610 | 0.020 |
Why?
|
| Granulocytes | 1 | 1992 | 546 | 0.020 |
Why?
|
| Incidence | 5 | 2012 | 20928 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2011 | 369 | 0.020 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1989 | 50 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1992 | 625 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 936 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1991 | 2505 | 0.020 |
Why?
|
| Micropore Filters | 1 | 1989 | 23 | 0.020 |
Why?
|
| Blood Preservation | 1 | 2010 | 177 | 0.020 |
Why?
|
| Immunity, Active | 1 | 1989 | 60 | 0.020 |
Why?
|
| Algorithms | 3 | 2012 | 13853 | 0.020 |
Why?
|
| Blood Component Removal | 1 | 2010 | 125 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 2011 | 289 | 0.020 |
Why?
|
| Eczema | 1 | 2012 | 229 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2011 | 234 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2010 | 227 | 0.020 |
Why?
|
| Child Development | 2 | 2012 | 2222 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1992 | 1827 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2010 | 6608 | 0.020 |
Why?
|
| Borrelia | 1 | 1989 | 67 | 0.020 |
Why?
|
| Adrenal Glands | 1 | 2011 | 547 | 0.020 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2010 | 272 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2009 | 226 | 0.020 |
Why?
|
| Galactosylceramides | 1 | 2009 | 92 | 0.020 |
Why?
|
| Streptococcus pneumoniae | 3 | 2000 | 712 | 0.020 |
Why?
|
| Fatty Acids | 5 | 1984 | 1806 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2012 | 992 | 0.020 |
Why?
|
| Paneth Cells | 1 | 2009 | 100 | 0.020 |
Why?
|
| Peritoneal Dialysis | 1 | 1989 | 146 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 7276 | 0.020 |
Why?
|
| Cephalometry | 1 | 2010 | 382 | 0.020 |
Why?
|
| Peptides | 2 | 2000 | 4392 | 0.020 |
Why?
|
| Environmental Microbiology | 1 | 2008 | 46 | 0.020 |
Why?
|
| Lethal Dose 50 | 1 | 2008 | 77 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2015 | 1057 | 0.020 |
Why?
|
| Mice, Knockout | 3 | 2010 | 14554 | 0.020 |
Why?
|
| Ampicillin | 2 | 1978 | 138 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2009 | 124 | 0.020 |
Why?
|
| Massachusetts | 3 | 2003 | 8662 | 0.020 |
Why?
|
| Gossypium | 1 | 1987 | 36 | 0.020 |
Why?
|
| Tyrosine | 1 | 2012 | 1460 | 0.020 |
Why?
|
| Textiles | 1 | 1987 | 46 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2003 | 5100 | 0.020 |
Why?
|
| Axons | 2 | 1993 | 1681 | 0.020 |
Why?
|
| Eosinophils | 1 | 1993 | 953 | 0.020 |
Why?
|
| Dietary Fats | 1 | 1996 | 2017 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2012 | 1539 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 1993 | 671 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2010 | 471 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 647 | 0.020 |
Why?
|
| Chorion | 1 | 2008 | 117 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2014 | 1953 | 0.020 |
Why?
|
| Cell Wall | 4 | 1978 | 422 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1727 | 0.020 |
Why?
|
| Neutrophil Activation | 1 | 2008 | 186 | 0.020 |
Why?
|
| Disinfectants | 1 | 2008 | 116 | 0.020 |
Why?
|
| Quercetin | 1 | 2007 | 93 | 0.020 |
Why?
|
| Molecular Weight | 3 | 2000 | 2255 | 0.020 |
Why?
|
| Aged | 6 | 2013 | 162944 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 1661 | 0.020 |
Why?
|
| Ions | 2 | 2000 | 264 | 0.020 |
Why?
|
| Umbilical Cord | 1 | 2008 | 180 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2007 | 387 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 6974 | 0.020 |
Why?
|
| Diarrhea | 3 | 1997 | 1343 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 2012 | 742 | 0.020 |
Why?
|
| Endotoxins | 3 | 1995 | 525 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2015 | 1554 | 0.020 |
Why?
|
| Dinitrochlorobenzene | 1 | 1985 | 18 | 0.020 |
Why?
|
| Structure-Activity Relationship | 3 | 2000 | 3133 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 1423 | 0.020 |
Why?
|
| Genotype | 2 | 2015 | 12946 | 0.020 |
Why?
|
| Disinfection | 1 | 2008 | 191 | 0.020 |
Why?
|
| Personnel, Hospital | 1 | 2008 | 283 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 4143 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2010 | 664 | 0.020 |
Why?
|
| Coagulase | 1 | 1985 | 54 | 0.020 |
Why?
|
| Enterocytes | 1 | 2007 | 225 | 0.020 |
Why?
|
| Natural Killer T-Cells | 1 | 2009 | 315 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 3127 | 0.020 |
Why?
|
| Microscopy | 1 | 2011 | 903 | 0.020 |
Why?
|
| Transgenes | 1 | 2009 | 1009 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9410 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2010 | 754 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 1991 | 1801 | 0.020 |
Why?
|
| Disease Susceptibility | 2 | 2008 | 1780 | 0.020 |
Why?
|
| Mannitol | 1 | 1985 | 181 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2008 | 558 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 2008 | 389 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2009 | 1096 | 0.020 |
Why?
|
| Lincosamides | 1 | 2004 | 4 | 0.020 |
Why?
|
| Enteritis | 1 | 1985 | 160 | 0.020 |
Why?
|
| Cell Membrane | 4 | 1982 | 3744 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1979 | 1663 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1985 | 224 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2011 | 1265 | 0.020 |
Why?
|
| Deoxyribonucleases | 1 | 1985 | 214 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6365 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 2638 | 0.010 |
Why?
|
| Hexuronic Acids | 1 | 1984 | 144 | 0.010 |
Why?
|
| Sulfapyridine | 1 | 1983 | 5 | 0.010 |
Why?
|
| Aminosalicylic Acid | 1 | 1983 | 21 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2008 | 850 | 0.010 |
Why?
|
| Counterimmunoelectrophoresis | 1 | 1983 | 15 | 0.010 |
Why?
|
| Breath Tests | 1 | 2005 | 276 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15530 | 0.010 |
Why?
|
| Vasculitis | 1 | 2008 | 521 | 0.010 |
Why?
|
| Biotransformation | 1 | 1983 | 168 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 1224 | 0.010 |
Why?
|
| Pregnancy Trimesters | 1 | 2004 | 192 | 0.010 |
Why?
|
| Intestine, Large | 2 | 1981 | 71 | 0.010 |
Why?
|
| Skin Window Technique | 1 | 2003 | 22 | 0.010 |
Why?
|
| Sulfasalazine | 1 | 1983 | 79 | 0.010 |
Why?
|
| Streptomycin | 2 | 1981 | 69 | 0.010 |
Why?
|
| Maternal Exposure | 1 | 2010 | 961 | 0.010 |
Why?
|
| Age Factors | 3 | 1994 | 18355 | 0.010 |
Why?
|
| Guanine | 1 | 2004 | 274 | 0.010 |
Why?
|
| Mannose-Binding Lectin | 1 | 2004 | 150 | 0.010 |
Why?
|
| Crohn Disease | 2 | 1993 | 2301 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 2010 | 904 | 0.010 |
Why?
|
| Macrolides | 1 | 2004 | 201 | 0.010 |
Why?
|
| Immunoelectrophoresis | 2 | 1993 | 110 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4200 | 0.010 |
Why?
|
| Staphylococcus epidermidis | 1 | 2003 | 117 | 0.010 |
Why?
|
| Lincomycin | 2 | 1979 | 6 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2012 | 2452 | 0.010 |
Why?
|
| Smoking | 2 | 2010 | 8969 | 0.010 |
Why?
|
| Neutrophils | 2 | 1990 | 3711 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 2012 | 1726 | 0.010 |
Why?
|
| New York City | 1 | 2004 | 706 | 0.010 |
Why?
|
| Intestinal Perforation | 2 | 1981 | 252 | 0.010 |
Why?
|
| Lymphokines | 1 | 1985 | 949 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 991 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1990 | 2614 | 0.010 |
Why?
|
| Sterilization | 1 | 1982 | 134 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1981 | 329 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 1350 | 0.010 |
Why?
|
| Homeostasis | 1 | 2012 | 3335 | 0.010 |
Why?
|
| Hospitals | 1 | 2015 | 3937 | 0.010 |
Why?
|
| Pharynx | 1 | 2004 | 413 | 0.010 |
Why?
|
| Acute Disease | 1 | 2012 | 7141 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1985 | 1402 | 0.010 |
Why?
|
| Infection Control | 1 | 2008 | 962 | 0.010 |
Why?
|
| Biopsy | 4 | 1994 | 6756 | 0.010 |
Why?
|
| Proteins | 1 | 1996 | 6096 | 0.010 |
Why?
|
| Parents | 1 | 2014 | 3387 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2004 | 1146 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 62966 | 0.010 |
Why?
|
| Dental Pulp Diseases | 1 | 1980 | 13 | 0.010 |
Why?
|
| Dental Pulp Cavity | 1 | 1980 | 34 | 0.010 |
Why?
|
| Buffers | 1 | 2000 | 147 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1980 | 475 | 0.010 |
Why?
|
| Peer Review, Research | 1 | 2003 | 329 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 2295 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2006 | 3587 | 0.010 |
Why?
|
| Sprue, Tropical | 1 | 1979 | 6 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2000 | 370 | 0.010 |
Why?
|
| Spores, Bacterial | 1 | 1980 | 118 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2005 | 580 | 0.010 |
Why?
|
| Colonic Diseases | 1 | 1981 | 202 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2010 | 9639 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 1979 | 75 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2723 | 0.010 |
Why?
|
| Adenine | 1 | 2004 | 936 | 0.010 |
Why?
|
| Rifampin | 1 | 1981 | 315 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2009 | 3420 | 0.010 |
Why?
|
| Succinates | 2 | 1976 | 83 | 0.010 |
Why?
|
| Immune Sera | 1 | 1999 | 641 | 0.010 |
Why?
|
| Cholestyramine Resin | 1 | 1978 | 24 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 19862 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1999 | 256 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2007 | 13029 | 0.010 |
Why?
|
| Toxins, Biological | 1 | 1978 | 66 | 0.010 |
Why?
|
| Sulfamethoxazole | 1 | 1978 | 53 | 0.010 |
Why?
|
| Klebsiella | 1 | 1978 | 48 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2000 | 1161 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1997 | 115 | 0.010 |
Why?
|
| Age of Onset | 1 | 2005 | 3266 | 0.010 |
Why?
|
| Trimethoprim | 1 | 1978 | 91 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2005 | 1813 | 0.010 |
Why?
|
| Leukorrhea | 1 | 1977 | 4 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 1413 | 0.010 |
Why?
|
| Fatty Acids, Volatile | 2 | 1976 | 101 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3504 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1981 | 607 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1978 | 363 | 0.010 |
Why?
|
| United States | 4 | 2008 | 69693 | 0.010 |
Why?
|
| Hospitalization | 2 | 2013 | 10232 | 0.010 |
Why?
|
| Solubility | 1 | 1999 | 1083 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2009 | 3465 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1981 | 1368 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1999 | 1094 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1978 | 637 | 0.010 |
Why?
|
| Penicillins | 1 | 1979 | 378 | 0.010 |
Why?
|
| Immunochemistry | 2 | 1991 | 124 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 1999 | 844 | 0.010 |
Why?
|
| Sex Factors | 3 | 1994 | 10392 | 0.010 |
Why?
|
| Absorption | 1 | 1996 | 248 | 0.010 |
Why?
|
| Laboratories, Hospital | 1 | 1997 | 194 | 0.010 |
Why?
|
| Computer Systems | 1 | 1997 | 483 | 0.010 |
Why?
|
| Cephalosporins | 1 | 1977 | 203 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1999 | 810 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 1723 | 0.010 |
Why?
|
| Methods | 1 | 1976 | 1128 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 2354 | 0.010 |
Why?
|
| Peritonsillar Abscess | 1 | 1974 | 17 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1981 | 1608 | 0.010 |
Why?
|
| Nitrogen | 1 | 1996 | 343 | 0.010 |
Why?
|
| Peptococcus | 3 | 1978 | 5 | 0.010 |
Why?
|
| Electrochemistry | 1 | 1994 | 145 | 0.010 |
Why?
|
| Leucine | 1 | 1996 | 560 | 0.010 |
Why?
|
| Enterococcus faecalis | 1 | 1976 | 251 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1998 | 1155 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 5425 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13256 | 0.010 |
Why?
|
| Radiology Department, Hospital | 1 | 1997 | 412 | 0.010 |
Why?
|
| Neisseria meningitidis | 1 | 1993 | 109 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 1997 | 603 | 0.010 |
Why?
|
| Eubacterium | 3 | 1978 | 23 | 0.010 |
Why?
|
| Antigens, Ly | 2 | 1986 | 291 | 0.010 |
Why?
|
| Ileostomy | 1 | 1994 | 119 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 2133 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 6931 | 0.010 |
Why?
|
| Temperature | 1 | 1979 | 2207 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 3766 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1996 | 674 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1985 | 2542 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 1997 | 1179 | 0.010 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 1995 | 362 | 0.010 |
Why?
|
| Shigella | 1 | 1972 | 73 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2000 | 15056 | 0.010 |
Why?
|
| Salmonella typhi | 1 | 1993 | 200 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1980 | 1065 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1999 | 1255 | 0.010 |
Why?
|
| Glucose | 4 | 1978 | 4391 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1994 | 15244 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1985 | 2986 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29010 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1991 | 305 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 1993 | 224 | 0.010 |
Why?
|
| Health Maintenance Organizations | 1 | 1994 | 642 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2003 | 5385 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2004 | 5019 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 5724 | 0.010 |
Why?
|
| Data Collection | 1 | 2000 | 3339 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1976 | 2187 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1994 | 1589 | 0.010 |
Why?
|
| Basophils | 1 | 1992 | 389 | 0.010 |
Why?
|
| Skin | 1 | 2003 | 4353 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 1992 | 319 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 8541 | 0.010 |
Why?
|
| ROC Curve | 1 | 1997 | 3528 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2005 | 77098 | 0.010 |
Why?
|
| Necrosis | 1 | 1993 | 1643 | 0.010 |
Why?
|
| Chromatography, Gas | 2 | 1980 | 156 | 0.000 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1996 | 2014 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 20086 | 0.000 |
Why?
|
| Phenotype | 3 | 1986 | 16331 | 0.000 |
Why?
|
| Chi-Square Distribution | 1 | 1994 | 3510 | 0.000 |
Why?
|
| Mice, Nude | 2 | 1986 | 3689 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1992 | 2723 | 0.000 |
Why?
|
| Epitopes | 2 | 1985 | 2569 | 0.000 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1999 | 4379 | 0.000 |
Why?
|
| Barium Sulfate | 2 | 1978 | 180 | 0.000 |
Why?
|
| Weight Gain | 1 | 1996 | 2282 | 0.000 |
Why?
|
| Attitude of Health Personnel | 1 | 2000 | 3839 | 0.000 |
Why?
|
| Suppressor Factors, Immunologic | 1 | 1985 | 68 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 2 | 1993 | 9274 | 0.000 |
Why?
|
| Precancerous Conditions | 1 | 1992 | 971 | 0.000 |
Why?
|
| Rabbits | 1 | 1991 | 4886 | 0.000 |
Why?
|
| Drug Stability | 1 | 1985 | 290 | 0.000 |
Why?
|
| Uronic Acids | 1 | 1984 | 17 | 0.000 |
Why?
|
| Immunoassay | 1 | 1988 | 752 | 0.000 |
Why?
|
| Hexoses | 1 | 1984 | 30 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1985 | 668 | 0.000 |
Why?
|
| Amino Sugars | 1 | 1984 | 40 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 12958 | 0.000 |
Why?
|
| H-2 Antigens | 1 | 1982 | 365 | 0.000 |
Why?
|
| Chemical Fractionation | 1 | 1980 | 65 | 0.000 |
Why?
|
| Elapid Venoms | 1 | 1980 | 40 | 0.000 |
Why?
|
| Survival Rate | 1 | 1995 | 12773 | 0.000 |
Why?
|
| Complement C5 | 1 | 1980 | 111 | 0.000 |
Why?
|
| Precipitins | 1 | 1979 | 4 | 0.000 |
Why?
|
| Liver | 1 | 1996 | 7470 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15108 | 0.000 |
Why?
|
| Freund's Adjuvant | 1 | 1979 | 139 | 0.000 |
Why?
|
| Internship and Residency | 1 | 2000 | 5774 | 0.000 |
Why?
|
| Serum Albumin, Bovine | 1 | 1979 | 324 | 0.000 |
Why?
|
| Membranes | 1 | 1979 | 173 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1980 | 664 | 0.000 |
Why?
|
| Tooth | 1 | 1980 | 207 | 0.000 |
Why?
|
| Peptococcaceae | 1 | 1977 | 1 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1977 | 180 | 0.000 |
Why?
|
| Glucosamine | 1 | 1978 | 132 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1977 | 218 | 0.000 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1980 | 675 | 0.000 |
Why?
|
| Complement System Proteins | 1 | 1980 | 795 | 0.000 |
Why?
|
| Galactose | 1 | 1978 | 306 | 0.000 |
Why?
|
| Capillary Permeability | 1 | 1980 | 798 | 0.000 |
Why?
|
| Drug Therapy, Combination | 2 | 1977 | 6483 | 0.000 |
Why?
|
| Skin Tests | 1 | 1978 | 612 | 0.000 |
Why?
|
| Valerates | 1 | 1975 | 21 | 0.000 |
Why?
|
| Proteus | 1 | 1974 | 13 | 0.000 |
Why?
|
| Micrococcus | 1 | 1974 | 13 | 0.000 |
Why?
|
| Contraceptives, Oral | 1 | 1977 | 563 | 0.000 |
Why?
|
| Propionates | 1 | 1975 | 168 | 0.000 |
Why?
|
| Lactates | 1 | 1975 | 432 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1992 | 6347 | 0.000 |
Why?
|
| Cattle | 1 | 1979 | 3923 | 0.000 |
Why?
|
| Aging | 1 | 1992 | 8626 | 0.000 |
Why?
|
| Granuloma | 1 | 1974 | 315 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1972 | 468 | 0.000 |
Why?
|
| Digestive System | 1 | 1972 | 251 | 0.000 |
Why?
|
| Tonsillectomy | 1 | 1974 | 254 | 0.000 |
Why?
|
| Shigella flexneri | 1 | 1972 | 132 | 0.000 |
Why?
|
| Meat | 1 | 1974 | 595 | 0.000 |
Why?
|
| Glutamates | 1 | 1972 | 398 | 0.000 |
Why?
|
| Cell Count | 1 | 1975 | 1831 | 0.000 |
Why?
|
| Binding Sites | 1 | 1977 | 6115 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1972 | 1586 | 0.000 |
Why?
|
| Lipids | 1 | 1978 | 3302 | 0.000 |
Why?
|